Baillie Gifford & Co
ORTX

Baillie Gifford & Co’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Baillie Gifford & Co’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-274,000
Closed -$11.3M – 435
2020
Q3 		$11.3M Hold
274,000
– – 0.01% 204
2020
Q2 		$16.4M Hold
274,000
– – 0.01% 182
2020
Q1 		$20.6M Hold
274,000
– – 0.02% 145
2019
Q4 		$37.7M Buy
274,000
+181,500
+196% +$22.1M 0.04% 137
2019
Q3 		$11M Hold
92,500
– – 0.01% 176
2019
Q2 		$12.9M Hold
92,500
– – 0.01% 182
2019
Q1 		$16.5M Hold
92,500
– – 0.02% 168
2018
Q4 		$14.6M Buy
+92,500
New +$13.8M 0.02% 166

Other funds holding ORTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return